BioLineRx Ltd. (BLRX)Healthcare | Biotechnology | Hevel Modi'in, Israel | NasdaqCM
2.45 USD
+0.06
(2.510%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.41 -0.04 (-0.038%) ⇩ (April 17, 2026, 7:20 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 12:01 a.m. EDT
High-risk speculative biotech with deteriorating fundamentals (catalyst trust depleting) and severe price decay (+27% over 6 months). While recent partnership news offers a tiny glimmer of hope, the technical setup is broken with significant distance from moving averages; this is not a buy opportunity absent a major binary event. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.094325 |
| AutoARIMA | 0.147709 |
| AutoETS | 0.148189 |
| MSTL | 0.148333 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 33.54 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.173 |
| Excess Kurtosis | -1.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 43.478 |
| Market Cap | 11,023,557 |
| Trailing P/E | Infinity |
| Forward P/E | -3.66 |
| Beta | 0.48 |
| Profit Margins | -99.58% |
| Website | https://www.biolinerx.com |
As of April 19, 2026, 12:01 a.m. EDT: Options activity is extremely sparse with negligible volume across all expirations. Call Open Interest (OI) is concentrated at out-of-the-money strikes (5.0 and 6.0 for May '26), while Put OI is completely absent. This near-total lack of short-side positioning suggests no significant speculative beta flow is currently pricing in downside risk, despite the stock's technical deterioration. Implied Volatility data is missing, indicating low spectral interest.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.15517241 |
| Address1 | Modi’in Technology Park |
| Address2 | 2 HaMa’ayan Street |
| All Time High | 4,122.0 |
| All Time Low | 2.15 |
| Ask | 2.48 |
| Ask Size | 1 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 10,920 |
| Average Daily Volume3 Month | 14,021 |
| Average Volume | 14,021 |
| Average Volume10Days | 10,920 |
| Beta | 0.482 |
| Bid | 2.39 |
| Bid Size | 1 |
| Book Value | 4.2 |
| City | Hevel Modi'in |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.45 |
| Current Ratio | 1.953 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.4601 |
| Day Low | 2.3489 |
| Debt To Equity | 43.478 |
| Dividend Date | 1,563,148,800 |
| Earnings Call Timestamp End | 1,774,269,000 |
| Earnings Call Timestamp Start | 1,774,269,000 |
| Earnings Timestamp | 1,774,269,000 |
| Earnings Timestamp End | 1,779,885,000 |
| Earnings Timestamp Start | 1,779,885,000 |
| Ebitda | -10,060,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -635.28 |
| Enterprise To Revenue | 5,416.032 |
| Enterprise Value | 6,390,918,144 |
| Eps Current Year | -1.09 |
| Eps Forward | -0.67 |
| Eps Trailing Twelve Months | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 8 642 9101 |
| Fifty Day Average | 2.6152 |
| Fifty Day Average Change | -0.1652 |
| Fifty Day Average Change Percent | -0.06316916 |
| Fifty Two Week Change Percent | -15.517241 |
| Fifty Two Week High | 7.77 |
| Fifty Two Week High Change | -5.3199997 |
| Fifty Two Week High Change Percent | -0.68468463 |
| Fifty Two Week Low | 2.15 |
| Fifty Two Week Low Change | 0.29999995 |
| Fifty Two Week Low Change Percent | 0.13953486 |
| Fifty Two Week Range | 2.15 - 7.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,311,773,400,000 |
| Float Shares | 2,498,157,749 |
| Forward Eps | -0.67 |
| Forward P E | -3.6567163 |
| Free Cashflow | -3,875,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 20 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.80508006 |
| Gross Profits | 950,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03995 |
| Held Percent Institutions | 0.01097 |
| Implied Shares Outstanding | 4,499,411 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,738,195,200 |
| Last Split Factor | 1:40 |
| Long Business Summary | BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. |
| Long Name | BioLineRx Ltd. |
| Market | us_market |
| Market Cap | 11,023,557 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_5015080 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -1,175,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 11,319,264 |
| Number Of Analyst Opinions | 2 |
| Open | 2.39 |
| Operating Cashflow | -8,074,000 |
| Operating Margins | -17.45361 |
| Payout Ratio | 0.0 |
| Phone | 972 8 642 9100 |
| Post Market Change | -0.037500143 |
| Post Market Change Percent | -1.5306181 |
| Post Market Price | 2.4125 |
| Post Market Time | 1,776,468,026 |
| Previous Close | 2.39 |
| Price Eps Current Year | -2.2477064 |
| Price Hint | 4 |
| Price To Book | 0.5833334 |
| Price To Sales Trailing12 Months | 9.341997 |
| Profit Margins | -0.99575996 |
| Quick Ratio | 1.76 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.059999943 |
| Regular Market Change Percent | 2.5104578 |
| Regular Market Day High | 2.4601 |
| Regular Market Day Low | 2.3489 |
| Regular Market Day Range | 2.3489 - 2.4601 |
| Regular Market Open | 2.39 |
| Regular Market Previous Close | 2.39 |
| Regular Market Price | 2.45 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 7,930 |
| Return On Assets | -0.16112 |
| Return On Equity | -0.110089995 |
| Revenue Growth | -0.983 |
| Revenue Per Share | 0.0 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,351,357 |
| Shares Percent Shares Out | 0.0376 |
| Shares Short | 163,818 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 169,422 |
| Short Name | BioLineRx Ltd. |
| Short Percent Of Float | 0.0377 |
| Short Ratio | 11.26 |
| Source Interval | 15 |
| Symbol | BLRX |
| Target High Price | 23.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 17.5 |
| Target Median Price | 17.5 |
| Total Cash | 20,876,000 |
| Total Cash Per Share | 0.008 |
| Total Debt | 10,150,000 |
| Total Revenue | 1,180,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.0 |
| Trailing P E | Infinity |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.36055 |
| Two Hundred Day Average Change | -0.9105499 |
| Two Hundred Day Average Change Percent | -0.27095264 |
| Type Disp | Equity |
| Volume | 7,930 |
| Website | https://www.biolinerx.com |
| Zip | 7,177,871 |